Fertility Preservation for Pediatric and Adolescent Patients With Cancer: Medical and Ethical Considerations
Sigal Klipstein, Mary E. Fallat, Stephanie Savelli, Mary E. Fallat, Aviva L. Katz, Aviva L. Katz, Robert Macauley, Mark R. Mercurio, Margaret Moon, Alexander L. Okun, Kathryn L. Weise, Zora R. Rogers, Carl E. Allen, James S. Harper, Jeffrey H. Lipton, Cynthia Wetmore, Hope P. Wilson, Amber M. Yates, Frederick J. Rescorla, Mary L. Brandt, Michael G. Caty, Kurt F. Heiss, George Holcomb, Rebecca L. Meyers, R. Lawrence Moss, R. Lawrence Moss
Abstract
Many cancers presenting in children and adolescents are curable with surgery, chemotherapy, and/or radiotherapy. Potential adverse consequences of treatment include sterility, infertility, or subfertility as a result of gonad removal, damage to germ cells as a result of adjuvant therapy, or damage to the pituitary and hypothalamus or uterus as a result of irradiation. In recent years, treatment of solid tumors and hematologic malignancies has been modified in an attempt to reduce damage to the gonadal axis. Simultaneously, advances in assisted reproductive technology have led to new possibilities for the prevention and treatment of infertility. This clinical report reviews the medical aspects and ethical considerations that arise when considering fertility preservation in pediatric and adolescent patients with cancer.